AVDL logo

Avadel Pharmaceuticals (AVDL)

Profile

Full Name

Avadel Pharmaceuticals plc

Ticker Symbol

AVDL

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Ireland

IPO

June 7, 1996

Indexes

Not included

Website

http://www.avadel.com

Employees

188

Key Details

Price

$7.64

Market Cap

$738.25M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$169.12M(+504.79% YoY)

Annual EPS

-$0.51(+74.50% YoY)

PE Ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.64
AVDL price is $7.64

Price All-time High

$42.85
AVDL price is currently -82.17% below its historical high of $42.85

Price Most Recent Change

-1.93%
AVDL price was down -1.93% on Apr 1, 2025

Price YTD Change

-26.54%
AVDL price is down -26.54% since January 1st

Price 1-year Change

-54.14%
AVDL price is down -54.14% year-on-year

Price 3-year Change

+9.93%
AVDL price is up +9.93% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$738.25M
AVDL market capitalization is $738.25 million

Market Cap 3-year Change

+79.94%
AVDL market capitalization is up +79.94% over the past 3 years

Market Cap All-time High

$1.83B
AVDL market capitalization is currently -59.55% below its historical high of $1.83 billion

Market Cap Sector Rank

73.34%
AVDL market capitalization is higher than 73.34% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.55%
AVDL shares outstanding is up +0.55% year-on-year

Shares Outstanding 3-Year Change

+63.69%
AVDL shares outstanding is up +63.69% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.59
AVDL beta is 0.59

200-day SMA

$12.13
AVDL price is currently -37.03% below its 200-day simple moving average

50-day SMA

$8.16
AVDL price is currently -6.37% below its 50-day simple moving average

RSI

35.31
AVDL 14-day relative strength index is 35.31

Volume

0.81
AVDL 30-day relative volume is 0.81

ATR

$0.36
AVDL average true range is $0.36

10-day Historical Volatility

26.90%
AVDL 10-day historical volatility is 26.90%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$169.12M
AVDL annual revenue is $169.12 million

Revenue Analysts Estimate

$249.16M
AVDL annual revenue is currently -32.13% lower than the consensus analysts' forecast

Revenue 1-year Change

+504.79%
AVDL annual revenue is up +504.79% year-on-year

Revenue Sector Rank

62.18%
AVDL annual revenue is higher than 62.18% of companies in Healthcare sector

EPS

EPS

-$0.51
AVDL annual earnings per share is -$0.51

EPS Analysts Estimate

$0.15
AVDL annual earnings per share is currently -432.03% lower than the consensus analysts' forecast

EPS 1-year Change

+74.5%
AVDL annual earnings per share is up +74.5% year-on-year

EPS Sector Rank

68.4%
AVDL annual earnings per share is higher than 68.4% of companies in Healthcare sector

Profit

Gross Profit

$153.84M
AVDL annual gross profit is $153.84 million

Gross Margin

90.97%
AVDL annual gross profit margin is 90.97%

Operating Profit

-$42.40M
AVDL annual operating income is -$42.40 million

Operating Margin

-25.07%
AVDL annual operating profit margin is -25.07%

Net Income

-$48.83M
AVDL annual net profit is -$48.83 million

Net Margin

-28.87%
AVDL annual net profit margin is -28.87%

Expenses

Total Expenses

$211.52M
AVDL annual total expenses is $211.52 million

Operating Expenses

$196.24M
AVDL annual total operating expenses is $196.24 million

Cost Of Goods Sold

$15.28M
AVDL annual cost of goods sold is $15.28 million

Selling, General & Administrative Expenses

$181.04M
AVDL annual SGA is $181.04 million

Depreciation And Amortization

$2.68M
AVDL annual depreciation & amortization is $2.68 million

Interest Expense

$10.83M
AVDL annual interest expense is $10.83 million

Income Tax

-$247.00K
AVDL annual income tax is -$247.00 thousand

EBIT & EBITDA

EBIT

-$38.25M
AVDL annual earnings before interest & taxes is -$38.25 million

EBITDA

-$35.57M
AVDL annual EBITDA is -$35.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$164.24M
AVDL annual total assets is $164.24 million

Non Current Assets

$30.03M
AVDL annual long term assets is $30.03 million

Current Assets

$134.21M
AVDL annual total current assets is $134.21 million

Cash And Cash Equivalents

$51.37M
AVDL annual cash & cash equivalents is $51.37 million

Accounts Receivable

$34.10M
AVDL annual accounts receivable is $34.10 million

Inventory

$20.30M
AVDL annual inventory is $20.30 million

Liabilities

Total Liabilities

$90.39M
AVDL annual total liabilities is $90.39 million

Long Term Liabilities

$41.55M
AVDL annual total long term liabilities is $41.55 million

Current Liabilities

$48.83M
AVDL annual total current liabilities is $48.83 million

Accounts Payable

$7.33M
AVDL annual accounts payable is $7.33 million

Debt

Total Debt

$1.70M
AVDL annual total debt is $1.70 million

Total Debt 1-year Change

-35.06%
AVDL annual total debt is down -35.06% year-on-year

Long Term Debt

$1.12M
AVDL annual long term debt is $1.12 million

Short Term Debt

$582.00K
AVDL annual short term debt is $582.00 thousand

Equity & Capital

Shareholders Equity

$73.85M
AVDL annual stockholders equity is $73.85 million

Book Value

$73.85M
AVDL annual book value is $73.85 million

Retained Earnings

-$794.33M
AVDL annual retained earnings is -$794.33 million

Working Capital

$85.37M
AVDL annual working capital is $85.37 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$46.91M
AVDL annual cash flow from operations is -$46.91 million

Cash From Operations 1-year Change

+63.5%
AVDL annual cash flow from operations is up +63.5% year-on-year

Cash From Investing

$51.78M
AVDL annual cash flow from investing activities is $51.78 million

Cash From Investing 1-year Change

+203.37%
AVDL annual cash flow from investing activities is up +203.37% year-on-year

Cash From Financing

$15.97M
AVDL annual cash flow from financing activities is $15.97 million

Cash From Financing 1-year Change

-88.2%
AVDL annual cash flow from financing activities is down -88.2% year-on-year

CAPEX

CAPEX

-
AVDL annual capital expenditures value is unknown

CAPEX 1-year Change

-
AVDL annual capital expenditures 1-year change is unknown

Free Cash Flow

Free Cash Flow

-$46.91M
AVDL annual free cash flow is -$46.91 million

Free Cash Flow 1-year Change

+63.5%
AVDL annual free cash flow is up +63.5% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

90.97%
AVDL annual gross profit margin is 90.97%

Operating Margin

-25.07%
AVDL annual operating profit margin is -25.07%

Net Margin

-28.87%
AVDL annual net profit margin is -28.87%

ROA & ROE

ROA

-29.69%
AVDL annual return on assets is -29.69%

ROE

-60.44%
AVDL annual return on equity is -60.44%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
AVDL price to earnings ratio value is unknown

PE Ratio Sector Rank

-
AVDL price to earnings ratio is unknown

PB Ratio

PB Ratio

10.00
AVDL price to book ratio is 10.00

PB Ratio Sector Rank

92.04%
AVDL price to book ratio is higher than 92.04% of companies in Healthcare sector

PS Ratio

PS Ratio

4.37
AVDL price to sales ratio is 4.37

PS Ratio Sector Rank

62.24%
AVDL price to sales ratio is higher than 62.24% of companies in Healthcare sector

Enterprise value

Enterprise Value

$688.58M
AVDL enterprise value is $688.58 million

Enterprise Value Sector Rank

71.86%
AVDL enterprise value is higher than 71.86% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-19.36
AVDL EV/EBITDA is -19.36

EV/EBITDA Sector Rank

6.82%
AVDL EV/EBITDA is higher than 6.82% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

2.75
AVDL annual current ratio is 2.75

Quick Ratio

2.33
AVDL annual quick ratio is 2.33

Leverage

Debt To Equity

0.00
AVDL annual debt to equity ratio is 0.00

Interest Coverage Ratio

-3.53
AVDL annual interest coverage ratio is -3.53

Risk & Stability

Piotroski F-Score

3
AVDL piotroski f-score is 3

Altman Z-Score

-0.99
AVDL altman z-score is -0.99

Analyst ratings

Recent major analysts updates

Mar 4, 25 Needham
Buy
Mar 4, 25 HC Wainwright & Co.
Buy
Mar 3, 25 Needham
Buy
Feb 11, 25 Deutsche Bank
Buy
Jan 13, 25 UBS
Buy
Jan 10, 25 Piper Sandler
Overweight
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 9, 25 Needham
Buy
Nov 12, 24 Needham
Buy
Oct 31, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

HCSG logo
Healthcare Services (HCSG)
EMBC logo
Embecta (EMBC)
PRAX logo
Praxis Precision Medicines (PRAX)
OMI logo
Owens & Minor (OMI)
XERS logo
Xeris Biopharma Holdings (XERS)
EOLS logo
Evolus (EOLS)
NTLA logo
Intellia Therapeutics (NTLA)
CRON logo
Cronos (CRON)
AXGN logo
AxoGen (AXGN)
  • What is the ticker symbol for Avadel Pharmaceuticals?
  • Does Avadel Pharmaceuticals pay dividends?
  • What sector is Avadel Pharmaceuticals in?
  • What industry is Avadel Pharmaceuticals in?
  • What country is Avadel Pharmaceuticals based in?
  • When did Avadel Pharmaceuticals go public?
  • Is Avadel Pharmaceuticals in the S&P 500?
  • Is Avadel Pharmaceuticals in the NASDAQ 100?
  • Is Avadel Pharmaceuticals in the Dow Jones?
  • When was Avadel Pharmaceuticals's last earnings report?
  • When does Avadel Pharmaceuticals report earnings?
  • Should I buy Avadel Pharmaceuticals stock now?

What is the ticker symbol for Avadel Pharmaceuticals?

The ticker symbol for Avadel Pharmaceuticals is NASDAQ:AVDL

Does Avadel Pharmaceuticals pay dividends?

No, Avadel Pharmaceuticals does not pay dividends

What sector is Avadel Pharmaceuticals in?

Avadel Pharmaceuticals is in the Healthcare sector

What industry is Avadel Pharmaceuticals in?

Avadel Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Avadel Pharmaceuticals based in?

Avadel Pharmaceuticals is headquartered in Ireland

When did Avadel Pharmaceuticals go public?

Avadel Pharmaceuticals's initial public offering (IPO) was on June 7, 1996

Is Avadel Pharmaceuticals in the S&P 500?

No, Avadel Pharmaceuticals is not included in the S&P 500 index

Is Avadel Pharmaceuticals in the NASDAQ 100?

No, Avadel Pharmaceuticals is not included in the NASDAQ 100 index

Is Avadel Pharmaceuticals in the Dow Jones?

No, Avadel Pharmaceuticals is not included in the Dow Jones index

When was Avadel Pharmaceuticals's last earnings report?

Avadel Pharmaceuticals's most recent earnings report was on Mar 3, 2025

When does Avadel Pharmaceuticals report earnings?

The next expected earnings date for Avadel Pharmaceuticals is May 8, 2025

Should I buy Avadel Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page